Literature DB >> 2917201

Acute nonlymphocytic leukemia (M2) with chromosome abnormality trisomy 4 developing eight years after radiation therapy for breast cancer.

S Yokota1, M Taniwaki, T Okuda, T Maekawa, K Nishida, S Misawa, T Takino, T Abe, Y Urata.   

Abstract

We report here the development, 8 years after radiation therapy for breast cancer, of acute nonlymphocytic leukemia (ANLL), type M2 of the FAB classification, in which trisomy 4 was detected as the only chromosomal abnormality. Simultaneous observation of cytologic and cytogenetic features of individual colonies derived from leukemic progenitor (L-CFU) and early progenitor (CFU mix) cultures in this patient revealed that all colonies examined had a normal karyotype, although the clone with trisomy 4 was predominant in the direct bone-marrow culture. These findings suggest that progenitor cells with trisomy 4 were less predominant in colony growth when stimulated by colony-stimulating factors (CSFs) than were stem cells with a normal karyotype.

Entities:  

Mesh:

Year:  1989        PMID: 2917201     DOI: 10.1007/BF00320232

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  11 in total

1.  Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells.

Authors:  A W Burgess; E M Wilson; D Metcalf
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

2.  Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neurtophilic granulocytes and erythroblasts.

Authors:  A A Fauser; H A Messner
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

3.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

4.  New chromosome banding techniques with base specific antibiotics and fluorochromes for qualified identification of marker chromosomes in leukemia and related disorders.

Authors:  M Taniwaki
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1985-09

5.  Trisomy 4: another specific anomaly in acute nonlymphocytic leukemia.

Authors:  F Prieto; L Badía; M A Orts; L Dieguez; V Amigo
Journal:  Cancer Genet Cytogenet       Date:  1987-05

6.  Trisomy 4: an entity within acute nonlymphocytic leukemia.

Authors:  A A Sandberg; R Morgan; S N Sait; R Berger; G Flandrin; S Schrier; F Hecht
Journal:  Cancer Genet Cytogenet       Date:  1987-05

7.  Prefixation treatment with ethidium bromide for high resolution banding analysis of chromosomes from cultured human bone marrow cells.

Authors:  S Misawa; S Horiike; M Taniwaki; T Abe; T Takino
Journal:  Cancer Genet Cytogenet       Date:  1986-08

8.  Cytogenetic evidence of clonal proliferation of leukemic progenitor cells from patients with acute promyelocytic leukemia (APL).

Authors:  S Yokota; Y Sonoda; T Okuda; T Maekawa; H Nishigaki; S Misawa; T Takino; T Abe
Journal:  Leuk Res       Date:  1988       Impact factor: 3.156

9.  A method for obtaining high quality chromosome preparations from single hemopoietic colonies on a routine basis.

Authors:  I D Dubé; C J Eaves; D K Kalousek; A C Eaves
Journal:  Cancer Genet Cytogenet       Date:  1981-10

10.  Trisomy 4 identifies a subset of acute nonlymphocytic leukemias.

Authors:  C Mecucci; A Van Orshoven; G Tricot; J L Michaux; A Delannoy; H Van den Berghe
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.